|
|
Volumn 38, Issue 1, 2008, Pages 30-32
|
|
Cabergoline for suppression of puerperal lactation in a prevention of mother-to-child HIV-transmission programme in rural Malawi
a
b,e
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CABERGOLINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
ERGOLINE DERIVATIVE;
PROLACTIN;
ADULT;
ARTICLE;
DIZZINESS;
DRUG EFFICACY;
DRUG SAFETY;
EPIGASTRIC PAIN;
FEMALE;
HEALTH PROGRAM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION PREVENTION;
LACTATION INHIBITION;
MAJOR CLINICAL STUDY;
MALAWI;
OUTCOME ASSESSMENT;
PUERPERIUM;
SINGLE DRUG DOSE;
VIRUS TRANSMISSION;
CLINICAL TRIAL;
DISEASE TRANSMISSION;
DRUG ANTAGONISM;
DRUG EFFECT;
LACTATION;
RURAL POPULATION;
ADULT;
DISEASE TRANSMISSION, VERTICAL;
DOPAMINE AGONISTS;
ERGOLINES;
FEMALE;
HIV INFECTIONS;
HUMANS;
LACTATION;
MALAWI;
POSTPARTUM PERIOD;
PROLACTIN;
RURAL POPULATION;
|
|
EID: 43049166022
PISSN: 00494755
EISSN: 17581133
Source Type: Journal
DOI: 10.1258/td.2007.060091 Document Type: Article |
|
Times cited : (10)
|
|
References (7)
|
